Trial Profile
An Open Label, Randomized, Two Part Study to Evaluate the CYP2C8- and OATP1B1-Mediated Drug-Drug Interaction Potential of GSK1278863 With Pioglitazone and Rosuvastatin as Victims and Trimethoprim as Perpetrator in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jun 2023
Price :
$35
*
At a glance
- Drugs Daprodustat (Primary) ; Pioglitazone (Primary) ; Rosuvastatin (Primary) ; Trimethoprim (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors GSK
- 11 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 19 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 27 Feb 2015 New trial record